2026-09-17Company announcement
NVIDIA Inception
MY ROBOTS announced approval to join NVIDIA Inception in September 2026. The linked NVIDIA page provides general program information.
Programs & milestones
Programs, participation and milestones.
Selection and participation records, with links to the relevant announcements. NVIDIA participation is a company announcement; its external link explains the program.
Updated: October 5, 2026
2026-07-08Selected · StartX AI cohort of 20
JETRO GSAP 2026 — StartX AI
MY ROBOTS is listed among the 20 companies in the StartX AI course. JETRO announced 62 selected companies across the GSAP courses on July 8, 2026.
2026-08-13Selected · Foundational cohort of 10
J-StarX US Healthcare Breakthrough — Foundational
JETRO named MY ROBOTS among the 10 Foundational companies on August 13, 2026. The announcement covers 15 companies across two courses.
2026-06-23Shortlisted — 15 startups / Mentorship Phase
Qualcomm AI Program for Innovators 2026 — APAC
Qualcomm named MY ROBOTS K.K. among 15 shortlisted startups advancing to the Mentorship Phase. Demo Day is planned for November 2026; the schedule is subject to change.
2026-04-24Selected · MedTech
HVC KYOTO 2026
Kyoto Research Park lists MY ROBOTS in the MedTech selection for HVC KYOTO 2026. This records selection, without implying finalist or award status.
2026-08-03Network participation · Aug 2026
AstraZeneca i2.JP
The i2.JP news page announced MY ROBOTS K.K. as a new partner on August 3, 2026.
2026-10-07 – 2026-10-09Scheduled exhibitor · Booth V-83
Japan Healthcare Venture Summit 2026
Scheduled to exhibit on October 7–9, 2026 at PACIFICO Yokohama, Booth V-83. See the official exhibitor listing for event information.
Past program participation
2025-09-30 / 2026-03-30Past participation · 2025–2026
J-StarX Medtech — 2025–2026
JETRO listed MY ROBOTS among 15 Phase 1 companies on September 30, 2025, and among six companies in its Australia program report on March 30, 2026.
The linked articles describe the company at the time of publication. Our current focus is Surgical Knowledge Infrastructure.
Program participation does not establish customer adoption, clinical efficacy, regulatory approval, investment or product endorsement.